Medical Device Markets

Innovation is Being Redefined During COVID-19

Augmedics helped redefine the word innovation for the medtech industry. But not in the way you think. MD+DI Managing Editor Omar Ford breaks down why and what this means going forward.

June 26, 2020

Just what does innovation mean during COVID-19. We're offered up a pretty big clue when we look at the recent actions of Chicago, IL-based Augmedics, a company that has developed the xvision Spine system (XVS), an augmented reality surgical image guidance technology.

MD+DI Managing Editor Omar Ford explains why the company's recent financing round is the perfect example of how companies should think of innovation going forward.

About the Author

Omar Ford

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

See more from Omar Ford

You May Also Like